当前位置: 首页 > 详情页

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Xuanwu Hospital, Capital Medical University,Beijing,Beijing,China,100053 [2]Maanshan People's Hospital,Ma'anshan,Anhui,China [3]Suzhou Municipal Hospital of Anhui Province,Suzhou,Anhui,China [4]Luoyang Central Hospital Affiliated to Zhengzhou University,Luoyang,Henan,China [5]Nanyang Central Hospital,Nanyang,Henan,China [6]First People's Hospital of Zhengzhou City,Zhengzhou,Henan,China [7]Xihua County People's Hospital,Zhoukou,Henan,China [8]Northern Jiangsu People's Hospita!,Yangzhou,Jiangsu,China [9]Liaocheng Third People's Hospital,Liaocheng,Shandong,China

研究目的:
The objective of this study is to evaluate the effectiveness and safety of endovascular therapy combined with 25% human albumin in the treatment of acute large vessel occlusive stroke.

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院